Benzinga

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Benzinga

Premium Services
Financial News
Financial News
Large Cap Stocks
Small-Cap Stocks
Insider Trades
Earnings
Technology
AI News
Personal Finance
ETF News
Crypto News
Dividend News
Latest Rumors
Latest Offerings News
Investment Ideas
Investment Ideas
Stock of the Day
Stock Whisper Index
Analyst Ratings
Analyst Color
Financial Advisors
Government Trades
Trading Ideas
Stock Screener
Markets
Markets
Premarket Movers
After Hours
Options
ETFs
Commodities
Prediction Markets
Private Markets
Bonds
Futures
Forex
Top Stocks
Top Stocks
Apple (AAPL)
Tesla (TSLA)
Amazon (AMZN)
Nvidia (NVDA)
Alphabet (GOOGL)
Meta Platforms (META)
Microsoft (MSFT)
StreetTracks Gold Shares (GLD)
IBIT Bitcoin Trust (IBIT)
Top Value Stocks
Top Momentum Stocks
Top Growth Stocks
Top Quality Stocks
Learn
Learn
Investing Guides
Personal Finance
Mortgages
Best Credit Cards
Best Dividend Stocks
Best Swing Trade Stocks

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

LeanLife Health Inc Stock News

LNLHFOTCEM

Trade with Public

Trade with Public

$0.000001

At close: Dec 18, 4:00 PM EST

Latest LeanLife Health Stock News | OTC:LNLHF | Benzinga

Get the latest news on LeanLife Health stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on LeanLife Health performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, December 18, 2025

PRO
Washington Post Reported President Trump Expe...
Benzinga Newsdesk

Wednesday, December 17, 2025

PRO
'Trump to sign executive order reclassifying ...
Benzinga Newsdesk

Tuesday, June 10, 2025

PRO
'GOP-Led Congressional Panel Demands Investig...
Benzinga Newsdesk

Wednesday, March 05, 2025

PRO
Watching Cannabis Stocks; Marijuana Moment Re...
Benzinga Newsdesk

Wednesday, January 15, 2025

PRO
FDA Solicits Public Comments On Use Of Cannab...
Benzinga Newsdesk

Wednesday, December 11, 2024

PRO
Dropbox shares are trading higher after the c...
Benzinga Newsdesk

Wednesday, November 06, 2024

PRO
AP Reports Florida Voters Reject Cannabis Leg...
Benzinga Newsdesk

Wednesday, October 30, 2024

PRO
Microsoft shares are trading higher after the...
Benzinga Newsdesk

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investor Events
Pre-market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2026 Benzinga | All Rights Reserved